| 000 | 01794 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517195355.0 | ||
| 264 | 0 | _c20190614 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1435-5922 | ||
| 024 | 7 |
_a10.1007/s00535-018-1430-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHamada, Tsuyoshi | |
| 245 | 0 | 0 |
_aStatin use and pancreatic cancer risk in two prospective cohort studies. _h[electronic resource] |
| 260 |
_bJournal of gastroenterology _cAug 2018 |
||
| 300 |
_a959-966 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xepidemiology |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSmoking _xepidemiology |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 700 | 1 | _aKhalaf, Natalia | |
| 700 | 1 | _aYuan, Chen | |
| 700 | 1 | _aBabic, Ana | |
| 700 | 1 | _aMorales-Oyarvide, Vicente | |
| 700 | 1 | _aQian, Zhi Rong | |
| 700 | 1 | _aNowak, Jonathan Andrew | |
| 700 | 1 | _aNg, Kimmie | |
| 700 | 1 | _aKraft, Peter | |
| 700 | 1 | _aRubinson, Douglas Adam | |
| 700 | 1 | _aStampfer, Meir Jonathan | |
| 700 | 1 | _aGiovannucci, Edward Luciano | |
| 700 | 1 | _aFuchs, Charles Stewart | |
| 700 | 1 | _aOgino, Shuji | |
| 700 | 1 | _aWolpin, Brian Matthew | |
| 773 | 0 |
_tJournal of gastroenterology _gvol. 53 _gno. 8 _gp. 959-966 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00535-018-1430-x _zAvailable from publisher's website |
| 999 |
_c28008173 _d28008173 |
||